2022
DOI: 10.1016/j.arabjc.2021.103578
|View full text |Cite
|
Sign up to set email alerts
|

In silico drug-like properties prediction and in vivo antifungal potentials of Citrullus lanatus seed oil against Candida albicans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 24 publications
0
6
0
Order By: Relevance
“…Moreover, Apeh et al (2022) found that palmitic acid could act on SAP-5, a molecular target related to the antifungal effect. Also, Sandeep et al (2012) reported that palmitic acid is an inhibitor of topoisomerase I in cancer cells.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, Apeh et al (2022) found that palmitic acid could act on SAP-5, a molecular target related to the antifungal effect. Also, Sandeep et al (2012) reported that palmitic acid is an inhibitor of topoisomerase I in cancer cells.…”
Section: Discussionmentioning
confidence: 99%
“…Drug-likeness is a medicinal property employed in drug discovery to predict the pharmacokinetics-related failure of drugs in clinical trials with high precision. 54 , 55 This study investigated the drug-likeness of the top-scoring compounds, taking into consideration the “Rule of 5” (RO5) (MW < 500, Log P ⩽ 5, HBA ⩽ 10, and HBD ⩽ 5) by Lipinski et al 33 in addition to Veber et al 34 rule of Not < 5 and TPSA ⩽ 140 A 2 . Interestingly, all the compounds meet the RO5 and Veber rules, but rutin and their oral availability were also confirmed by their favorable bioavailability score (0.55%), which suggests that they are good oral drugs for the treatment of DM.…”
Section: Discussionmentioning
confidence: 99%
“…In the drug discovery and development process, about 50 and 40 % of drug candidates failed clinical trials due to unacceptable efficacy and toxicity, respectively [48]. Recently, in silico models such as SwissADME and PROTOX-II web servers are employed in drug development to predict the druggability and safety of drug candidates with high precision thereby saving time and cost of developing drugs that will fail clinical trials [25,49]. Drug likeness prediction of the test compounds was conducted based on the rule of five (RO5) by Lipinski et al [50] which states that an orally active drug must not violate more than one of these criteria's viz MW ≤ 500, HBD ≤ 5, HBA ≤ 10 and log P ≤ 5.…”
Section: Discussionmentioning
confidence: 99%